Global Malignant Mesothelioma market is expected to reach US$ 300 Mn by 2025

Market Research Reports Search Engine

A new report added to the repository of Market Research Reports Search Engine “Russia and China in APAC Region to be at the Forefront of the Malignant Mesothelioma Market” is a comprehensive repository of information, providing market share, size, and forecast.

Pemetrexed and combination segment is the largest segment by drug type in the global mperalignant mesothelioma market, which is estimated to represent close to US$ 160 Mn, or more than 45% revenue share of the total market in 2017 and more than US$ 300 Mn by the end of the forecast period of 2017–2025, expanding at CAGR of 8.4%. Pemetrexed and combination segment is expected to gain more than 300 BPS in market share in 2025 over 2017 owing to its better response rate of around 30%-40% when used singly or in combination with other drugs. Pemetrexed and combination drug type segment dominated the global malignant mesothelioma market in terms of revenue in 2016 and the trend is projected to grow throughout the forecast period. Pemetrexed and combination segment is also the most attractive segment, recording a market attractiveness index of 3.2 over the forecast period.

Increased focus to obtain approvals for efficient combination therapy procedures is one of the significant factors driving revenue growth of the Pemetrexed and combination drug type segment

Most of the companies in the global malignant mesothelioma market are focusing on collaborating with organizations to study the combination of several drugs on malignant mesothelioma. As there are very few companies that have patents for procedures, many companies are conducting clinical trials focusing on different combination drugs. For instance, in 2017, Boehringer Ingelheim entered into phase 3 for its double-blind, randomized, phase 3 study of Nintedanib in combination with Pemetrexed / Cisplatin followed by continuing Nintedanib monotherapy versus placebo in combination with Pemetrexed / Cisplatin followed by continuing placebo monotherapy for mesothelioma treatment. All these efforts by the key players in the market are boosting the growth of the Pemetrexed and combination segment.

It is assumed that asbestos exposure leads to malignant mesothelioma and given the restrictions on asbestos use globally, it is expected that cases of mesothelioma will reduce in the near future. However, the number of malignant mesothelioma cases do not support these assumptions. As per statistics released by the Cancer Research UK, 1 in every 140 men and 1 in every 710 women are diagnosed with malignant mesothelioma. It has been observed that there is an increasing trend of malignant mesothelioma cases in men. This particular factor is fuelling the growth in revenue of the Pemetrexed and combination segment.

Evaluation of combination therapies over monotherapy is one of the main factors creating a positive impact on the Pemetrexed and combination drug type segment. Combination therapies such as those using chemotherapy with radio, targeted antibody, cryotherapy, or with other immunotherapies are likely to expand the potential indications for various drugs. These combination therapies also seek to improve survival rates considerably, as has been evident from limited clinical data in comparison with only surgeries or radiation therapies. Various companies have identified that multiple pathways are affected in tumor regulation and hence seek to use combination therapy as a more effective method.

The highest CAGR of the Pemetrexed and combination drug type segment is likely to be recorded in the APEJ malignant mesothelioma market

Pemetrexed and combination drug type segment stands the most attractive in the Latin America malignant mesothelioma market, representing a market attractiveness index of 2.7. In the APAC and MEA regional markets, the segment is expected to reach the highest CAGR of 9.5% and 7.5% respectively during the period of forecast.

About MRRSE

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com

Global 3D cell culture market Is Driven by Increasing Requirement for Organ Transplantation

Variant-Market-Research-Logo-HP

Global 3D cell culture market Report, published by Variant Market Research, forecast that the global market is expected to reach $4,899 Million by 2024 from $920 Million in 2016, growing at a CAGR of 23.3% from 2016 to 2024.

3D cell culture includes the culture of biological cells in a micro-assembles devices, where artificially formed three-dimensional environment aids the growth of these cells. The micro-environment parameters of the growing cells in three-dimensional cell culture systems, can be regulated and observed to a certain extent. 3d cell culture market trend include growing developments in the field of analytical systems and cell imaging, cells have been progressively grown in 3D cell culture, which are useful in many applications like 3d cell culture and drug discovery. Moreover, 3d cell culture applications are disease pathology, tissue morphogenesis and engineering. This favors 3D cell culture market size.

Prevention on research and testing on animals to drive the global 3D cell culture market

The global 3D cell culture market growth is primarily driven by factors such as increasing requirement for organ transplantation due to large patient database, prevention on research and testing on animals, and growing investment on R&D by several biotechnological & pharmaceutical companies. Though, huge initial cost may hinder the market growth. Additionally, advancement of 3D cell culture for formulating custom-made cosmetics in countries such as U.S., UK would provide several growth opportunities for the market in the forecasted period.

Market Segmentation

The major segments of the global 3D cell culture market, technology, application, end-user, and geography. Based on technology, the market is categorized into Scaffold free platform, extracellular matrices, bioreactors, gels, and microchips. Application segment includes tissue engineering, research, drug discovery, stem cell biology, and clinical applications. Moreover, end-user has been segmented into biotechnology & biopharmaceutical industry, research laboratories & institutes, and hospital & diagnostic centers. Based on geography, market is segmented as North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Extracellular matrices accounted for the largest market share in the technology segment

In 2016, extracellular matrices held the largest market share in the technology segment, followed by bioreactors, due to accessibility of a significant number of products based on a framework reinforced 3d cell culture.

Biotechnology & biopharmaceutical industry accounted for the largest market share in the end-user segment

In 2016, biotechnology & biopharmaceutical industry held the major market share in the end-user segment, followed by research laboratories & institutes, due to increasing execution of technology in the drug discovery protocols to carry out effective screening and target authentication.

Asia-Pacific is anticipated to grow at a fastest CAGR over the forecast period

In the year 2016, 3D Cell Culture Market Forecast that Asia Pacific is anticipated to grow at a fastest CAGR of 24.5%, during the forecast period, followed by North America, due to growing government subsidy for research and development in countries such as South Korea and India and increasing scope for outsourcing. Moreover, Europe held the major market share followed by North America.

Competitive Landscape

Major players have used various strategies to increase their market share and global presence. The major companies operating in the market are Lonza Group, Dickinson and Company, Merck & Co., Inc., 3D Biotek LLC, Kuraray Co., Ltd., Corning Incorporated, Becton, Advanced Biomatrix, Inc., Thermo Fisher Scientific Inc., Global Cell Solutions, Inc., and VWR International, LLC, among others.

Scope of the Global 3D Cell Culture Market

Technology Segments

  • Extracellular Matrices
  • Bioreactors
  • Gels
  • Scaffold Free Platform
  • Microchips

Application Segments

  • Research
  • Drug Discovery
  • Tissue Engineering
  • Clinical Applications
  • Stem Cell Biology

End-User Segments

  • Research Laboratories & Institutes
  • Biotechnology & Biopharmaceutical Industry
  • Hospital & Diagnostic Centers

Geography Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • South Korea
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

About Variant Market Research

Variant Market Research offers syndicated and customized reports to fulfill clients’ objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise is data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.

Contact Us:

Michael Mendes

Head – Sales

Variant Market Research

649 Mission St, 5th Floor, San Francisco, CA 94105, United States.

Tel: +1-415-680-2785

Fax: +1-415-680-2786

Email: michael.mendes@variantmarketresearch.com

 

Priya Sharma is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO. Her hobbies are increasing social appearance and browsing on web.

Global Cell and Tissue Culture Supplies Market Is Boosted by Increasing Demand for Artificial Organs

Variant-Market-Research-Logo-HP

Global Cell and Tissue Culture Supplies Market Report, published by Variant Market Research, forecast that the global market is expected to reach $36,744 million by 2024 from $17,863 million in 2016, growing at a CAGR of 9.4% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 10.5% and 10.0%, respectively, during the forecast period.

The global cell and tissue culture supplies market is majorly driven by rising investments on R&D for cell-based research and tissue engineering, increasing demand for artificial organs, growing requirement for serums and vaccines, and growing usage of cell and tissue culture. However, complexity of cell culture techniques and moral concern over mishandling of animals can hinder the market growth. Also, rising adoption of customized media solutions and increasing third-party research contracts would provide several growth opportunities in forecasted period.

The global cell and tissue culture supplies market has been bifurcated into type, application, and geography. The type segment is segmented into consumable products (media, sera, reagent, contamination detection kits, cryoprotective agents) and instruments (incubators, culture systems, biosafety cabinets, cryostorage equipment, roller bottle equipment, pipetting instruments and others). Additionally, application segment is categorized into vaccine production, biopharmaceutical production, toxicity testing, gene therapy, drug screening & development, cancer research and others. By type, instruments held the major market share in 2016, while, consumable products are expected to reach fastest CAGR during the forecast period 2016 – 2024. Furthermore, biopharmaceutical dominated the applications segment by major market share, followed by vaccine production in 2016. In terms of growth, vaccine production is anticipated to be predominant in the forecast period.

Based on geography, the global cell and tissue culture supplies market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted for the maximum market share with 49.4% in 2016, followed by Europe with 25.9%. Whereas, Asia-pacific is projected to dominate at a fastest CAGR during the forecast period 2016 to 2024, owing to, growing demand for drug discovery, increasing need for automated cell culture process, and growing number of people suffering from chronic diseases.

The key players operating in this market are VWR International, STEMCELL Technologies Inc., Wheaton Industries, Inc., Corning, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Lonza Group AG, Promo cell GmbH, GE Healthcare, and Eppendorf AG, among others.

Scope of the Global Cell and Tissue Culture Supplies Market

  • Consumable Products
    • Media
      • Serum Free Media
      • Classical Media
      • Specialty Media
      • Lysogeny Broth
      • Chemically Defined Media
      • Protein Free Media
    • Reagent
      • Protease Inhibitors
      • Growth Factors & Cytokines
      • Thrombin
      • Albumin
      • Amino Acids
      • Other Reagents
    • Sera
      • Fetal Bovine Serum
      • Other Seras
    • Contamination Detection Kits
    • Cryoprotective Agents
  • Instruments
    • Culture Systems
      • Tissue Culture Flasks
      • Multiple Well Plates
      • Roller Bottles
      • Bioreactors
      • Culture Bags
      • Culture Dishes
    • Incubators
    • Biosafety Cabinets
    • Cryostorage Equipment
    • Roller Bottle Equipment
    • Pipetting Instruments
    • Other Instruments

Application Segments

  • Vaccine Production
  • Biopharmaceutical Production
  • Toxicity Testing
  • Gene Therapy
  • Drug Screening & Development
  • Cancer Research
  • Other Applications

Geography Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Other
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

About Variant Market Research

Variant Market Research offers syndicated and customized reports to fulfil clients’ objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise is data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.

Contact Us:

Michael Mendes

Head – Sales

Variant Market Research

649 Mission St, 5th Floor, San Francisco,

CA 94105, United States.

Tel: +1-415-680-2785

Fax: +1-415-680-2786

Email: michael.mendes@variantmarketresearch.com

Email: help@variantmarketresearch.com

Priya Sharma is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO. Her hobbies are increasing social appearance and browsing on web.

The global cell and tissue culture supplies market is propelled by increasing need for artificial organs

Global Cell and Tissue Culture Supplies Market Report, published by Variant Market Research, forecast that the global market is expected to reach $36,744 million by 2024 from $17,863 million in 2016, growing at a CAGR of 9.4% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 10.5% and 10.0%, respectively, during the forecast period.

Cell or tissue culture is a procedure which includes isolating of a tissue from plant or animal and transferring to an artificial environment under controlled conditions. Cell and tissue culture experiments requires a wide range of equipment and supplies for growing and monitoring the cultures. Type, application, and geography are the major bifurcations considered in the global cell and tissue culture supplies market.

The factors driving the growth of the global cell and tissue culture supplies market includes increasing demand for artificial organs, rising investments in R&D for advanced cell-based research and tissue engineering, increasing occurrence of chronic diseases, and surge in the demand for serum and vaccines. Though, complication involved in cell culture procedures and ethical concern over misuse of animals would pose challenge for the development of the market. Besides, mounting demand for tailored media solutions, and increasing third party research contracts would create several growth opportunities in years to come.

Type, application, and geography are the major segmentations considered in the global cell and tissue culture supplies market. By type, the segment is categorized as consumable products (media (serum free media, classical media, specialty media, lysogeny broth, chemically defined media, and protein free media), reagent (protease inhibitors, growth factors & cytokines, thrombin, albumin, amino acids, and others), sera (fetal bovine serum and others), contamination detection kits, cryoprotective agents) and instruments (culture systems (tissue culture flasks, multiple well plates, roller bottles, bioreactors, culture bags and culture dishes), incubators, biosafety cabinets, cryostorage equipment, roller bottle equipment, pipetting instruments and others). Furthermore, applications are sub-segmented as vaccine production, biopharmaceutical production, toxicity testing, gene therapy, drug screening & development, cancer research and others.

Instruments accounted the largest market share in type segment in the year 2016, followed by consumable products, whereas, consumable products will attain fastest CAGR. Biopharmaceutical production accounted the largest market share in the application segment, followed by vaccine production in 2016.

The global cell and tissue culture supplies market by geography is bifurcated as North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted the market share with 49.4% in 2016, followed by Europe with 25.9%. While, Asia-pacific is predicted to attain fastest CAGR during the forecast period 2016 to 2024, driven by, increasing need for mechanized cell culture process, rising demand for drug discovery and growing number of people suffering from chronic diseases.

The key players considered in this market comprises of STEMCELL Technologies Inc., VWR International, Wheaton Industries, Inc., Corning, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Lonza Group AG, Promo cell GmbH, Eppendorf AG, and GE Healthcare, among others.

Scope of the Global Cell and Tissue Culture Supplies Market

  • Consumable Products
    • Media
      • Serum Free Media
      • Classical Media
      • Specialty Media
      • Lysogeny Broth
      • Chemically Defined Media
      • Protein Free Media
    • Reagent
      • Protease Inhibitors
      • Growth Factors & Cytokines
      • Thrombin
      • Albumin
      • Amino Acids
      • Other Reagents
    • Sera
      • Fetal Bovine Serum
      • Other Sera’s
    • Contamination Detection Kits
    • Cryoprotective Agents
  • Instruments
    • Culture Systems
      • Tissue Culture Flasks
      • Multiple Well Plates
      • Roller Bottles
      • Bioreactors
      • Culture Bags
      • Culture Dishes
    • Incubators
    • Biosafety Cabinets
    • Cryostorage Equipment
    • Roller Bottle Equipment
    • Pipetting Instruments
    • Other Instruments

Application Segments

  • Vaccine Production
  • Biopharmaceutical Production
  • Toxicity Testing
  • Gene Therapy
  • Drug Screening & Development
  • Cancer Research
  • Other Applications

Geography Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Other
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

About Variant Market Research

Variant Market Research offers syndicated and customized reports to fulfil clients’ objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.

Contact Us:
Variant Market Research
Tel: +1-415-680-2785
Tel: +91 20 65337795
Fax: +1-415-680-2786

Priya Sharma is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO. Her hobbies are increasing social appearance and browsing on web.

Global 3D Cell Culture Market Is Boosted by Increasing Requirement for Organ Transplantation

Variant-Market-Research-Logo-HP

Global 3D Cell Culture Market Report, published by Variant Market Research, forecast that the global market was valued at $920 Billion in 2016 and expected to reach $4,899 Billion by 2024; growing at a CAGR of 23.3% from 2016 to 2024. In geographical segments By, Asia Pacific and North America anticipated to grow at a fastest CAGR of 24.5% and 23.2%, respectively, over the forecast period 2016 – 2024.

The global 3D cell culture market is majorly driven by prohibition about research and testing on animals, increasing requirement for organ transplantation due to huge patient database, and growing investment on R&D by different biotechnological and pharmaceutical companies. Though, High initial cost may hinder the growth of the market. Moreover, increasing demand for customized cosmetic would unfold attractive business opportunities for the market in the coming years.

The global 3D cell culture market has been segmented into Technology, application, and geography. Technology segment includes gels, extracellular matrices, bioreactors, Scaffold free platform, and microchips. By application, the market is segmented into tissue engineering, research, drug discovery, clinical applications, and stem cell biology. Moreover, end-user is bifurcated into biotechnology & biopharmaceutical industry, hospital & diagnostic centers, and research laboratories & institutes.

Geographically, the global 3D cell culture market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). Asia-Pacific is predicted to grow at a fastest CAGR over the forecast period 2016-2024, driven by growing government support for R&D and increasing opportunity for outsourcing. Furthermore, Europe held the major market share followed by North America, in the year 2016.

The major key players operating in the global 3D cell culture market are Becton, Merck & Co., Inc., 3D Biotek LLC, Lonza Group, Kuraray Co., Ltd., Corning Incorporated, Dickinson and Company, Advanced Biomatrix, Inc., Thermo Fisher Scientific Inc., Global Cell Solutions, Inc., and VWR International, LLC, among others.

Scope of the Global 3D Cell Culture Market

Technology Segments

  • Extracellular Matrices
  • Bioreactors
  • Gels
  • Scaffold Free Platform
  • Microchips

Application Segments

  • Research
  • Drug Discovery
  • Tissue Engineering
  • Clinical Applications
  • Stem Cell Biology

End-User Segments

  • Research Laboratories & Institutes
  • Biotechnology & Biopharmaceutical Industry
  • Hospital & Diagnostic Centers

Geography Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • South Korea
    • Others
  • RoW
    • South America
    • Middle East
    • Africa

About Variant Market Research

Variant Market Research offers syndicated and customized reports to fulfil clients’ objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.

Contact Us:
Variant Market Research
Tel: +1-415-680-2785
Tel: +91 20 65337795
Fax: +1-415-680-2786
Email: sales@variantmarketresearch.com

Priya Sharma is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO. Her hobbies are increasing social appearance and browsing on web.

North America region dominated the global Cell and Tissue Culture Supplies Market

Global Cell and Tissue Culture Supplies Market Report, published by Variant Market Research, forecast that the global market is expected to reach $36,744 million by 2024 from $17,863 million in 2016, growing at a CAGR of 9.4% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 10.5% and 10.0%, respectively, during the forecast period.

Major drivers of global cell and tissue culture supplies market are increasing demand for artificial organs, increasing investments on R&D for cell-based research and tissue engineering, and growing need for serums and vaccines, among others. Although, complexity of cell culture techniques and moral concern over mismanagement of animals may hamper the growth of the market. Moreover, growing demand for customized media solutions and third-party contracts would provide several market scopes in the coming years.

Type, application, and geography are the major segments of the global cell and tissue culture supplies market. Type segment comprises instruments (culture systems, incubators, biosafety cabinets, cryostorage equipment, roller bottle equipment, pipetting instruments and others), and consumable products (media, reagent, sera, contamination detection kits, cryoprotective agents). Instruments expected to dominate the market with highest market over the forecast period 2016 – 2024. Additionally, application segment is further bifurcated into biopharmaceutical production, vaccine production, toxicity testing, drug screening & development, gene therapy, and cancer research, among others. Biopharmaceutical held the highest market share in 2016.

Geography segment is further categorized into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted the highest market share in 2016 and expected to continue its dominance over the forecast period 2016 – 2024. Asia-Pacific is anticipated to grow at a fastest CAGR from 2016 to 2024, driven by increasing need for automated cell culture process, and growing demand for drug discovery.

Major players of cell and tissue culture supplies market are Thermo Fisher Scientific, Inc., STEMCELL Technologies Inc., Wheaton Industries, Inc., Corning, Inc., Merck KGaA, Lonza Group AG, VWR International, Promo cell GmbH, Eppendorf AG, and GE Healthcare, among others.

About Variant Market Research:

Variant Market Research LLP was delineated in 2015 and to launch our business and website it grabbed more than a year. Our head office is based in Pune and we also have branch in San Francisco, California, the U.S. The long time was generally used to build up a talented team of experienced professionals and analysts, to generate client satisfying exact market analysis data. The company aims to be a specialist in delivering reports on various domains with precise analysis, keeping a virtuous relationship with our consumers. Our vision says, “We would like to grow with you, making your paths simpler yet solidest” and our mission is to “Implementing our analytical, technical and marketing skills to set a new goal for our consumers, dedicatedly helping them take their next strategic moves.”

The Co-founders of Variant Market Research: M/S Shweta Shubham and Mr. Yogesh Godse are keen to provide services across aforementioned domains helping them to take their strategic moves regarding their business and providing them the growth opportunities. The Co-founders say, “We believe in providing the future solutions for your business, exploring the current market trends and suggesting you the future strategies and forecast of a particular market that could keep your company ahead in the competitive market rivalry.” We hold expertise in our designated areas of research and consulting with a team of experts from each of the dedicated areas covered under our research. Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic move and take your company’s future ahead with our support and your esteemed cooperation.

For information, contact:

VARIANT MARKET RESEARCH LLP

Address

649 Mission St.,5th Floor, San Francisco,

CA 94105, United States.

Tel: +1-415-680-2785

Fax: +1-415-680-2786

Priya Sharma is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO. Her hobbies are increasing social appearance and browsing on web.

3D Cell Culture Market Is Anticipated to Witness Double Digit CAGR, Driven by Rising Need for Organ Transplantation

Global 3D Cell Culture Market Report, published by Variant Market Research, forecast that the global market is expected to reach $4,899 Billion by 2024 from $920 Billion in 2016, growing at a CAGR of 23.3% from 2016 to 2024.

The global 3D cell culture market is majorly driven by prohibition on research & testing on animals, rising need for organ transplantation due to large patient database, and growing investment on R&D by various pharmaceutical and biotechnological companies. High initial cost is one of the major restraining factors of the market. Rising demand for customized cosmetics is a growth opportunity for the market players.

The global 3D cell culture market has been segmented into technology, application, and geography Technology segment includes extracellular matrices, scaffold free platform, bioreactors, gels, and microchips. Application segmented into research, drug discovery, clinical applications, tissue engineering, and stem cell biology. Additionally, end-user is further bifurcated into research laboratories & institutes, hospital & diagnostic centers, and biotechnology & biopharmaceutical industry.

Get Free Sample of This Report @ https://www.variantmarketresearch.com/report-categories/life-sciences/3d-cell-culture-market/sample-request

Geographical segments of the global 3D cell culture market are North America, Europe, Asia-Pacific, and Rest of the World (RoW). Asia Pacific is anticipated to grow at a fastest CAGR from 2016 to 2024, driven by growing government funding for research and development and increasing scope for outsourcing. Furthermore, Europe held the highest market share followed by North America, in the year 2016.

The key players of 3D cell culture market are

  • Merck & Co., Inc.
  • Lonza Group
  • 3D Biotek LLC
  • Kuraray Co., Ltd.
  • Becton
  • Dickinson and Company
  • Corning Incorporated
  • Advanced Biomatrix, Inc.
  • Thermo Fisher Scientific Inc.
  • Global Cell Solutions, Inc., and VWR International, LLC, among others.

About Variant Market Research:

Variant Market Research LLP was delineated in 2015 and to launch our business and website it grabbed more than a year. Our head office is based in Pune and we also have branch in San Francisco, California, the U.S. The long time was generally used to build up a talented team of experienced professionals and analysts, to generate client satisfying exact market analysis data. The company aims to be a specialist in delivering reports on various domains with precise analysis, keeping a virtuous relationship with our consumers. Our vision says, “We would like to grow with you, making your paths simpler yet solidest” and our mission is to “Implementing our analytical, technical and marketing skills to set a new goal for our consumers, dedicatedly helping them take their next strategic moves.”

The Co-founders of Variant Market Research: M/S Shweta Shubham and Mr. Yogesh Godse are keen to provide services across aforementioned domains helping them to take their strategic moves regarding their business and providing them the growth opportunities. The Co-founders say, “We believe in providing the future solutions for your business, exploring the current market trends and suggesting you the future strategies and forecast of a particular market that could keep your company ahead in the competitive market rivalry.” We hold expertise in our designated areas of research and consulting with a team of experts from each of the dedicated areas covered under our research. Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic move and take your company’s future ahead with our support and your esteemed cooperation.

For information, contact:

VARIANT MARKET RESEARCH LLP

Address

649 Mission St.,

5th Floor, San Francisco,

CA 94105, United States.

Tel: +1-415-680-2785

Fax: +1-415-680-2786

Priya Sharma is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO. Her hobbies are increasing social appearance and browsing on web.